CD44 and gastric cancer: To determine whether Ad-Bmi-1i has inhibitory or killing effect on gastric CSC-like cells, we detected the expression of CD133 and CD44 by Immunohistochemistry (IHC) in Ad-Bmi-1i treated gastric cancer xenografts (Ad-Bmi-1i) and in control group (Ad-Ctrli).